‘Social enterprise’ pharma company routes drug profits to patients

A new Australian pharmaceutical company is planning to route any profits made from selling generic drugs to patient support and medical research organisations.

‘For Benefit Medicines’ will sell two aromatase inhibitors, anastrozole and letrozole, marketed with the FBM logo, with profits to be evenly distributed between the Breast Cancer Network Australia and Breast Cancer Institute of Australia.